FDA Investigator Lisa M Feola
Lisa M Feola has inspections in 2 countries as of 01 Aug 2023. Lisa M Feola has collaborated with a combined 1069 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
4
Last Inspection Date:
01 Aug 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America,
Denmark
Co-Investigator(s):
Alicia M Mozzachio,
Amy M Cramer,
Ann Marie Montemurro,
Ann Marie Schofield,
Annemarie B Randow,
Annemarie Bodnar,
Barbara Jwilimczyk Macri,
Barry Cherney, PhD,
Brian D Nicholson,
Bruce H Mccullough,
Byungja E Marciante,
Carrie Ann Plucinski,
Christina A Miller,
Christina V Santos,
Daniel J Grabicki,
David Perkins,
Debra I Love,
Emest F Bizjak,
Frederick Razzaghi,
Geneve M Maxwell,
Geneve M Parks,
Gianine E Tompkins,
Humera Khan,
James R Birkenstamm,
Jason F Chancey,
Jeanne M Morris,
Karen K Moksnes,
Karen Takahashi,
Kristy A Zielny,
Lequita M Mayhew,
Liatte Kreuger, PharmD,
Lisa M Bellows,
Lorelei S Jarrell,
Maria A Bienkowski,
Maria A Reed,
Marie Bbuen Bigornia,
Michael R Klapal,
Mihaly S Ligmond,
Nicholas F Lyons,
Nicholas P Diorio,
Nicole J Clausen,
Nyungja E Marciente,
Paul L Bellamy,
Paula A Trost,
Phung Thien Nguyen,
Ralph A Erickson,
Rebecca K Olin,
Rona Leblanc, PhD,
Russ R Rivy,
Russell K Riley,
Sarah M Meng,
Sarah M Napier,
Steven D Kehoe,
Susan P Bruederle,
Thomas E Friel,
Tiffani D Wilson,
Todd M Stankewicz,
Tonia F Bernard,
Yumi J Hiramine
Lisa M Feola's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2002 | FDA 483 Response | AbbVie Inc. - Form 483R, 2002-10-04 |
June, 2004 | FDA 483 Response | Fertin Pharma A/S - Form 483R, 2004-06-26 |
November, 2003 | FDA 483 | Alcami Corporation - Form 483, 2003-11-20 |
May, 2004 | FDA 483 Response | Steins Laboratorium A/S - Form 483R, 2004-06-24 |
September, 2002 | FDA 483 | AbbVie Inc. - Form 483, 2002-09-20 |
June, 2004 | EIR | Fertin Pharma A/S - EIR, 2004-07-13 |
May, 2004 | EIR | Steins Laboratorium A/S - EIR, 2004-06-30 |
May, 2004 | FDA 483 | Steins Laboratorium A/S - Form 483, 2004-05-25 |
November, 2003 | EIR | Alcami Corporation - EIR, 2003-11-20 |
November, 2003 | FDA 483 Response | Alcami Corporation - Form 483R, 2003-12-05 |
September, 2002 | EIR | AbbVie Inc. - EIR, 2002-09-20 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more